
VICTOZA DISPOPEN
By NOVO NORDISK INDIA PVT LTD
Contains: LIRAGLUTIDE 6 MG

Product Summary
Offer Price | ₹ 4525.4 |
---|---|
Your Savings | ₹ 798.60 (15% on MRP) |
About VICTOZA DISPOPEN
- VICTOZA DISPOPEN is a medication used for the treatment of type 2 diabetes mellitus and obesity. It belongs to a class of drugs called glucagon-like peptide-1 receptor agonists. VICTOZA DISPOPEN helps regulate blood sugar levels by increasing insulin secretion, decreasing glucagon release, and slowing down the emptying of the stomach. In addition to its blood sugar-lowering effects, VICTOZA DISPOPEN also promotes weight loss. It is administered as a once-daily injection and is available under the brand name Victoza for diabetes and Saxenda for obesity.
Uses of VICTOZA DISPOPEN
- Helps in managing type 2 diabetes
- Aids in weight loss
- Controls blood sugar levels
- Reduces cardiovascular risks
How VICTOZA DISPOPEN Works
- VICTOZA DISPOPEN stimulates insulin secretion, suppresses glucagon release, and slows down gastric emptying, helping to regulate blood sugar levels and promote weight loss.
- VICTOZA DISPOPEN is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the effects of the naturally occurring hormone GLP-1. By binding to GLP-1 receptors in the pancreas, VICTOZA DISPOPEN enhances insulin secretion in response to elevated blood sugar levels, thereby lowering blood glucose. It also reduces the release of glucagon, a hormone that increases blood sugar levels, leading to further blood sugar control. VICTOZA DISPOPEN slows down the emptying of the stomach, which helps regulate appetite and promotes satiety, leading to reduced food intake and weight loss. Additionally, it acts on the hypothalamus in the brain, affecting the central regulation of appetite and energy expenditure.
Dosage of VICTOZA DISPOPEN
- Dosage for Children: VICTOZA DISPOPEN is not recommended for use in children.
- Dosage for Adults: The initial recommended dose for adults is 0.6 mg once daily. The dosage can be increased to 1.2 mg or 1.8 mg based on individual response and tolerability.
Side Effects Of VICTOZA DISPOPEN
- Nausea
- Vomiting
- Diarrhea
- Hypoglycemia
- Pancreatitis risk
How to Store VICTOZA DISPOPEN
- Store in a refrigerator at 2-8°C (36-46°F)
- Do not freeze
- Protect from light
Frequently asked questions about VICTOZA DISPOPEN
VICTOZA DISPOPEN is used for managing type 2 diabetes and promoting weight loss in adults.
VICTOZA DISPOPEN is administered as a once-daily subcutaneous injection.
VICTOZA DISPOPEN can be used as a weight loss treatment in adults with obesity or overweight, even without diabetes.
Common side effects of VICTOZA DISPOPEN include nausea, vomiting, diarrhea, and the risk of hypoglycemia.
VICTOZA DISPOPEN should be used during pregnancy only if the potential benefits justify the potential risks to the fetus.
VICTOZA DISPOPEN's effects on blood sugar control and weight loss may be noticeable within a few weeks of starting treatment.
VICTOZA DISPOPEN is not addictive.
VICTOZA DISPOPEN can be used in combination with other diabetes medications, as prescribed by a healthcare professional.
References related to VICTOZA DISPOPEN
- Victoza® Non-Insulin | Victoza® (liraglutide) injection 1.2mg or 1.8mg. (2022). Retrieved June 15, 2023, from Victoza.com website: https://www.victoza.com/
- FDA. (2010). Victoza (liraglutide [rDNA origin] injection. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022341lbl.pdf
Ronak Makwana
Reviewed on 16 Jan 2024
Ronak Makwana
Reviewed on 16 Jan 2024
Very responsive staff.All drugs available at store
sunil Nayi
Reviewed on 21 Apr 2024
sunil Nayi
Reviewed on 21 Apr 2024
So good it's give information with medicine
shilpa purohit
Reviewed on 04 Sep 2023
shilpa purohit
Reviewed on 04 Sep 2023
Value for money I got a good discount on medicines
Tarun Ezava
Show More
Reviewed on 22 Jun 2023
Tarun Ezava
Reviewed on 22 Jun 2023
Awesome experience every time i get medicine on time and they have delivery on time also staff are v Show More
Mukesh Jain
Reviewed on 24 Jan 2024
Mukesh Jain
Reviewed on 24 Jan 2024
Proper medicine at big saving rate